Penatalaksanaan Anemia pada Penyakit Ginjal Kronik

Abstract: Anemia in chronic kidney disease (CKD) causes a decrease of quality life, and increases cardiovascular disease, cognitive impairment death. Management anemia CKD with iron erythropoiesis stimulating agents (ESA) could improve the patient's life. This study aimed to determine management focused on ESA. was literature review study. Literature searching performed by using three databases, namely ProQuest, Pubmed, ClinicalKey. After an adjustment based inclusion exclusion criteria, 10 journals were obtained. The results showed that intravenous (IV) faster superior option for correction than oral patients anemia. Correction ESA therapy significantly increase hemoglobin level. If transferrin saturation (TS) <20% serum ferritin (SF) <100 ng/ml CKD-ND CKD-PD, as well TS SF <200 CKD-HD, had be administered levels. In conclusion, anemia, status have evaluated first, therefore, administration level disease.
 Keywords: management; agents; anemia; disease
 
 Abstrak: pada penyakit ginjal kronik (PGK) menyebabkan penurunan kualitas hidup, peningkatan kardiovaskular, gangguan kognitif, dan kematian. Penatalaksanaan PGK dengan pemberian besi dapat meningkat-kan hidup pasien. Penelitian ini bertujuan untuk mengetahui penatalaksanaan fokus Jenis penelitian ialah pencarian data menggunakan tiga database yaitu Setelah dilakukan penyesuaian berdasarkan kriteria inklusi eksklusi didapatkan artikel yang review. Hasil menunjukkan bahwa intravena menjadi pilihan koreksi lebih cepat unggul dibandingkan terhadap penderita Koreksi terapi meningkatkan kadar secara bebrmakna. Jika saturasi transferin (ST) feritin (FS) PGK-ND PGK-PD, ST FS PGK-HD, dilanjutkan mening-katkan hemoglobin. Simpulan dalam perlu evaluasi terlebih dahulu agar hemoglobin.
 Kata kunci: besi; agent;